At the news
? NEUTRALIMPACT 2/10 144 filed Nov 2, 2026 at 17:27 ET
Two officers of Arcutis Biotherapeutics filed Form 144 notices on November 2, 2026, signaling intent to sell shares. Officer Masaru Matsuda plans to sell 1,219 shares (~$38,841) and Officer Patrick Burnett plans to sell 943 shares (~$30,047), both acquired through restricted stock vesting on November 1, 2026. The proposed sales are small relative to the company's $4.0B market cap and the officers' recent prior sales, making this a routine insider transaction with limited market impact.
- Masaru Matsuda (Officer) filed Form 144 to sell 1,219 shares of common stock, estimated value $38,841.48.
- Patrick Burnett (Officer) filed Form 144 to sell 943 shares of common stock, estimated value $30,047.19.
- Both proposed sales are for shares acquired through restricted stock vesting on November 1, 2026.
- Proposed sale date for both is November 2, 2026, on Nasdaq.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access